Medicare Enrolled

Dr. Mark Yockey, MD

Urology Physician · Orlando, FL
Low-engagement
2101 PARK CENTER DR STE 130, Orlando, FL 32835
4072986950
In practice since 2007 (18 years)
NPI: 1326239203 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yockey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yockey? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yockey

Dr. Mark Yockey is an urology physician in Orlando, FL, with 18 years in practice.

Between the years covered by Open Payments, Dr. Yockey received a total of $5,278 from 38 pharmaceutical and/or device companies across 142 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yockey is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice$ $5,278 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$5,278
Total received (2018-2024)
Avg $754/year across 7 years
Top 39% in FL for urology physician
38
Companies
142
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,813 (53.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,815 (34.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$650 (12.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$199
2023
$709
2022
$278
2021
$526
2020
$2,328
2019
$638
2018
$599

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Gyrus ACMI, Inc.
$1,815
Medtronic, Inc.
$663
Astellas Pharma US Inc
$628
PFIZER INC.
$329
Endo Pharmaceuticals Inc.
$295
NeoTract Inc.
$235
Myovant Sciences Inc.
$135
Teleflex LLC
$106
Janssen Biotech, Inc.
$84
Allergan, Inc.
$83
MEDIVATION FIELD SOLUTIONS LLC
$78
C. R. Bard, Inc. & Subsidiaries
$71
Rochester Medical Corporation
$63
Bayer HealthCare Pharmaceuticals Inc.
$52
180 Medical, Inc.
$52
Amgen Inc.
$51
Boston Scientific Corporation
$50
United Service Solutions LLC
$42
ABBVIE INC.
$36
Antares Pharma, Inc.
$36
C. R. BARD, INC. & SUBSIDIARIES
$34
Medtronic USA, Inc.
$32
AbbVie, Inc.
$29
Mission Pharmacal Company
$28
Myriad Genetic Laboratories, Inc.
$25
Allergan Inc.
$24
Bayer Healthcare Pharmaceuticals Inc.
$20
COLOPLAST CORP
$19
Smith+Nephew, Inc.
$19
Verity Pharmaceuticals Inc.
$19
Clarus Therapeutics Inc.
$18
Acerus Pharmaceuticals Corporation
$18
Laborie Medical Technologies Corp.
$16
Avadel Specialty Pharmaceuticals, LLC
$16
Sumitomo Pharma America, Inc.
$15
PROCEPT BioRobotics Corporation
$14
Retrophin, Inc.
$14
Wilmington Medical Supply, Inc.
$13
Top 3 companies account for 58.9% of total payments
Associated products mentioned in payments ›
(815) Thiola · ACTIVA · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · EDEX · Erleada · GEMTESA · GENERAL BPH · GENTLECATH · INTERSTIM · JATENZO · MAGIC3 · MYRBETRIQ · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · PROLARIS · Prolia · ReTrace · Stravix · TOVIAZ · Trelstar · Uribel · UroLift · UroLift System · Urocit-K · VIAGRA · XIAFLEX · XTANDI · XYOSTED · Xtandi · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (53%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a urology physician in Orlando?
Compare urology physicians in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
107
Per 100K population
7.4
County median income
$77,011
Nearest hospital
ASPIRE HEALTH PARTNERS
4.7 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Yockey is a urology physician, and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Yockey receive payments from pharmaceutical companies?
Yes. Dr. Yockey received a total of $5,278 from 38 companies across 142 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Yockey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →